✦ LIBER ✦

401 POSTER A phase I study of enzastaurin (ENZ), an oral PKC inhibitor, in combination with erlotinib (ERL) administered orally daily to patients with advanced solid malignancies

✍ Scribed by H.A. Wakelee; S.K. Padda; L. Chhatwani; M. San Pedro-Salcedo; Y. Krupitskaya; L. Musib; J.E. Latz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1202 ORAL A Phase I Study of the Potent

✍ L.R. Molife; S. Minton; J. Vitfell-Pedersen; E. Chen; D. Sullivan; L. Yan; A.M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 64 KB

428 POSTER A phase I dose-escalation stu

✍ Y. Onozawa; N. Boku; A. Fukutomi; A. Ohtsu; T. Doi; T. Yoshino; W. Koizumi; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 104 KB

1246 POSTER A Phase I Dose-escalation St

✍ G.S. Falchook; S. Fu; H.M. Amin; S.A. Piha-Paul; D.S. Hong; A. Naing; M.B. Kleve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

218 POSTER A phase I dose-escalation stu

✍ E. Calvo; G. Edelman; J. Baselga; E. Kwak; C. Scheffold; L. Nguyen; G.I. Shapiro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

379 POSTER A phase I study of XL184, a M

✍ R. Kurzrock; S. Sherman; D. Hong; C. Ng; J. Frye; L. Janisch; M.J. Ratain; R. Sa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB